Oxford BioMedica

Oxford Biomedica stock soars on rosy forecast, talks to buy ABL Europe
Reuters
Wed, 09/20/23 - 08:40 am
Oxford BioMedica
M&A
viral vectors
ABL Europe
cell therapy
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
Mon, 02/27/23 - 10:02 am
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
Oxford Biomedica's next CEO to start in March; Kåre Schultz ready to wrap up Teva tenure early
Endpoints
Wed, 11/23/22 - 07:36 am
Pharma CEOs
Frank Mathias
Oxford BioMedica
Kåre Schultz
Teva Pharmaceutical
Richard Francis
Oxford Biomedica signs up for 3 more years of making AstraZeneca COVID shots⁠—on an 'as needed basis'
Fierce Pharma
Fri, 07/1/22 - 10:29 am
COVID-19
AstraZeneca
Oxford BioMedica
vaccines
Boehringer Ingelheim Steps Up to the Plate for Cystic Fibrosis Patients
BioSpace
Tue, 10/19/21 - 10:59 pm
Boehringer Ingelheim
cystic fibrosis
BI 3720931
Oxford BioMedica
Oxford Biomedica sees new investment for manufacturing; Twist gets a partner to help build out discovery libraries 
Endpoints
Thu, 09/23/21 - 10:56 am
Oxford BioMedica
drug manufacturing
funding
Twist Bioscience
AstraZeneca shells out up to $60M to reserve more coronavirus shot capacity with Oxford Biomedica
Fierce Pharma
Tue, 09/1/20 - 10:48 am
AstraZeneca
vaccines
Oxford BioMedica
drug manufacturing
COVID-19
AZD1222
The coronavirus vaccine frontrunners have emerged. Here's where they stand
BioPharma Dive
Tue, 06/9/20 - 12:32 pm
COVID-19
vaccines
Moderna Therapeutics
Cansino Biologics
Pfizer
BioNTech
Novavax
Inovio
Oxford BioMedica
AstraZeneca
Merck
JNJ
Sanofi
GSK
After 11 years, Sanofi kicks backs the rights to unwanted gene therapies to Oxford Biomedica
Fierce Biotech
Mon, 06/8/20 - 11:32 pm
Oxford BioMedica
Sanofi
Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine
Fierce Pharma
Mon, 06/8/20 - 10:53 am
AstraZeneca
Oxford BioMedica
vaccines
drug manufacturing
COVID-19
CDMOs
Boehringer Ingelheim lands option on cystic fibrosis gene therapy
Fierce Biotech
Mon, 08/6/18 - 09:58 am
Boehringer Ingelheim
cystic fibrosis
Oxford BioMedica
gene therapy
Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica
CP Wire
Wed, 06/6/18 - 09:29 am
Axovant
Oxford BioMedica
AXO-Lenti-PD
Pro-Savin
Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica
Wed, 06/6/18 - 09:25 am
Axovant
Oxford BioMedica
Bioverativ inks $100M gene therapy deal with Oxford BioMedica
Endpoints
Thu, 02/15/18 - 10:06 am
Bioverativ
gene therapy
Oxford BioMedica
Sanofi
Profit finally in sight for gene therapy specialist Oxford Bio
Yahoo/Reuters
Wed, 08/23/17 - 10:07 pm
gene therapy
Oxford BioMedica
CTL019
Novartis
Novartis turns to Oxford BioMedica for a major CAR-T supply deal
Endpoints
Thu, 07/6/17 - 02:35 pm
Novartis
Oxford BioMedica
CAR-T
CTL019
Novartis taps Oxford BioMedica in $90M immuno-oncology deal
Fierce Biotech
Fri, 10/10/14 - 11:50 am
Novarti
Oxford BioMedica
immuno-oncology
lentivirus
Oxford gene trial makes eye disease breakthrough
FT.com
Thu, 01/16/14 - 06:52 am
Oxford BioMedica
choroideremia
gene therapy
blindness
Oxford Bio's failed cancer vaccine may help some
Reuters
Tue, 09/22/09 - 09:17 am
Oxford BioMedica
vaccines
cancer